Fresenius Kabi: No Launches From US Melrose Park Facility In 2021

Market Fears Warning Letter At Key US Facility

FDA entrance sign 2016
'Getting final clarity on this situation will require a physical inspection,' Kabi believes • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Manufacturing

More from Business